Fidelity Investments’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-736
| Closed | -$722 | – | 5578 |
|
|
2024
Q3 | $722 | Sell |
736
-35,109
| -98% | -$34.4K | ﹤0.01% | 4933 |
|
|
2024
Q2 | $54.5K | Buy |
35,845
+11,832
| +49% | +$18K | ﹤0.01% | 3564 |
|
|
2024
Q1 | $54.5K | Sell |
24,013
-745
| -3% | -$1.69K | ﹤0.01% | 3543 |
|
|
2023
Q4 | $72.5K | Sell |
24,758
-3,936
| -14% | -$11.5K | ﹤0.01% | 3350 |
|
|
2023
Q3 | $121K | Buy |
28,694
+215
| +0.8% | +$909 | ﹤0.01% | 3038 |
|
|
2023
Q2 | $250K | Buy |
28,479
+4,708
| +20% | +$41.3K | ﹤0.01% | 2884 |
|
|
2023
Q1 | $73.7K | Buy |
23,771
+252
| +1% | +$781 | ﹤0.01% | 3297 |
|
|
2022
Q4 | $287K | Sell |
23,519
-273
| -1% | -$3.33K | ﹤0.01% | 2900 |
|
|
2022
Q3 | $202K | Sell |
23,792
-1,858
| -7% | -$15.8K | ﹤0.01% | 3047 |
|
|
2022
Q2 | $416K | Sell |
25,650
-8,539
| -25% | -$138K | ﹤0.01% | 2902 |
|
|
2022
Q1 | $412K | Buy |
+34,189
| New | +$412K | ﹤0.01% | 3047 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | – | – | 4377 |
|
|
2021
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4394 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4286 |
|
|
2016
Q1 | – | Sell |
-143,180
| Closed | -$8.62M | – | 2671 |
|
|
2015
Q4 | $8.62M | Sell |
143,180
-690
| -0.5% | -$41.5K | ﹤0.01% | 2041 |
|
|
2015
Q3 | $6.94M | Hold |
143,870
| – | – | ﹤0.01% | 2074 |
|
|
2015
Q2 | $8.11M | Buy |
143,870
+55,614
| +63% | +$3.14M | ﹤0.01% | 2095 |
|
|
2015
Q1 | $15.7M | Hold |
88,256
| – | – | ﹤0.01% | 1828 |
|
|
2014
Q4 | $21M | Sell |
88,256
-2,940
| -3% | -$699K | ﹤0.01% | 1707 |
|
|
2014
Q3 | $20.3M | Sell |
91,196
-180
| -0.2% | -$40.1K | ﹤0.01% | 1726 |
|
|
2014
Q2 | $24.1M | Buy |
91,376
+10,640
| +13% | +$2.8M | ﹤0.01% | 1710 |
|
|
2014
Q1 | $26.2M | Buy |
+80,736
| New | +$26.2M | ﹤0.01% | 1645 |
|